The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Oncolytic viruses in cancer therapy
Open accessAbstract
Oncolytic virotherapy is a promising form of gene therapy for cancer, employing nature’s own agents to find and destroy malignant cells. The purpose of this review is to provide an introduction to this very topical field of research and to point out some of the current observations, insights and ideas circulating in the literature. We have strived to acknowledge as many different oncolytic viruses as possible to give a broader picture of targeting cancer using viruses. Some of the newest additions to the panel of oncolytic viruses include the avian adenovirus, foamy virus, myxoma virus, yaba-like disease virus, echovirus type 1, bovine herpesvirus 4, Saimiri virus, feline panleukopenia virus, Sendai virus and the non-human coronaviruses. Although promising, virotherapy still faces many obstacles that need to be addressed, including the emergence of virus-resistant tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sarinella, F., Calistri, A., Sette, P., Palù, G., & Parolin, C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302770 · Cited by 30
RetractedDown-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
Almilaji, A., Szteyn, K., Fein, E., Pakladok, T., Munoz, C., Elvira, B., Towhid, S. T., Alesutan, I., Shumilina, E., Bock, C.-T., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350083 · Cited by 8,675
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Rowe, W. P., Huebner, R. J., Gilmore, L. K., Parrott, R. H., & Ward, T. G. (1953) · Experimental Biology and Medicine · doi:10.3181/00379727-84-20714 · Cited by 1,114
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Ott, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,051
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., & Coen, D. M. (1991) · Science · doi:10.1126/science.1851332 · Cited by 1,050
Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976
Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00241-1 · Cited by 842
Stojdl, D. F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., & Bell, J. C. (2000) · Nature Medicine · doi:10.1038/77558 · Cited by 815
Liu, B. L., Robinson, M., Han, Z.-Q., Branston, R. H., English, C., Reay, P., McGrath, Y., Thomas, S. K., Thornton, M., Bullock, P., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301885 · Cited by 803
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
Fueyo, J., Gomez-Manzano, C., Alemany, R., Lee, P. S., McDonnell, T. J., Mitlianga, P., Shi, Y.-X., Levin, V. A., Yung, W. K. A., & Kyritsis, A. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203251 · Cited by 764
Reovirus Therapy of Tumors with Activated Ras Pathway
Coffey, M. C., Strong, J. E., Forsyth, P. A., & Lee, P. W. K. (1998) · Science · doi:10.1126/science.282.5392.1332 · Cited by 750
Genetic instability and darwinian selection in tumours
Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01661-x · Cited by 748
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L. M., et al. (1997) · Nature Medicine · doi:10.1038/nm1297-1354 · Cited by 668
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L., & Kirn, D. (2000) · Nature Medicine · doi:10.1038/80474 · Cited by 583
Recent progress in the battle between oncolytic viruses and tumours
Parato, K. A., Senger, D., Forsyth, P. A. J., & Bell, J. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1750 · Cited by 536
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Kirn, D., Martuza, R. L., & Zwiebel, J. (2001) · Nature Medicine · doi:10.1038/89901 · Cited by 502
Nemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackburn, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.289 · Cited by 471
Immune escape of tumors: apoptosis resistance and tumor counterattack
Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
Todo, T., Martuza, R. L., Rabkin, S. D., & Johnson, P. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101136398 · Cited by 465
Ganly, I., Kirn, D. H., Eckhardt, G., Rodriguez, G. I., Soutar, D. S., Otto, R., Robertson, A. G., Park, O., Gulley, M. L., Heise, C. C., et al. (2000) · PubMed · Cited by 432
Phase I/II Trial of Intravenous NDV-HUJ Oncolytic Virus in Recurrent Glioblastoma Multiforme
Freeman, A. I., Zakay-Rones, Z., Gomori, J. M., Linetsky, E., Rasooly, L., Greenbaum, E., Rozenman-Yair, S., Panet, A., Libson, E., Irving, C. S., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.016 · Cited by 407
McKee, T. D., Grandi, P., Mok, W., Alexandrakis, G., Insin, N., Zimmer, J. P., Bawendi, M. G., Boucher, Y., Breakefield, X. O., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2242 · Cited by 397
The Spontaneous Regression of Cancer: A review of cases from 1900 to 1987
Challis, G. B., & Stam, H. J. (1990) · Acta Oncologica · doi:10.3109/02841869009090048 · Cited by 372
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Butel, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.405 · Cited by 371
Cairns, R., Papandreou, I., & Denko, N. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0002 · Cited by 370
McCart, J. A., Ward, J. M., Lee, J., Hu, Y., Alexander, H. R., Libutti, S. K., Moss, B., & Bartlett, D. L. (2001) · PubMed · Cited by 366
Intergeneric poliovirus recombinants for the treatment of malignant glioma
Gromeier, M., Lachmann, S., Rosenfeld, M. R., Gutin, P. H., & Wimmer, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6803 · Cited by 363
Kelland, L. R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.028 · Cited by 352
Sinn, P. L., Sauter, S. L., & McCray, P. B. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302570 · Cited by 322
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
Fisher, K., Stallwood, Y., Green, N., Ulbrich, K., Mautner, V, & Seymour, L. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301389 · Cited by 316
Dewey, R. A., Morrissey, G., Cowsill, C. M., Stone, D., Bolognani, F., Dodd, N. J. F., Southgate, T. D., Klatzmann, D., Lassmann, H., Castro, M. G., et al. (1999) · Nature Medicine · doi:10.1038/15207 · Cited by 311
Fechner, H., Haack, A., Wang, H., Wang, X., Eizema, K., Pauschinger, M., Schoemaker, R. G., van Veghel, R., Houtsmuller, A. B., Schultheiss, H.-P., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301030 · Cited by 310
Reid, T. R., Galanis, E., Abbruzzese, J. L., Sze, D., Wein, L. M., Andrews, J., Randlev, B., Heise, C. C., Uprichard, M. J., Hatfield, M. J., et al. (2002) · PubMed · Cited by 309
Kim, J. H., Oh, J. Y., Park, B. H., Lee, D. E., Kim, J. S., Park, H. E., Roh, M. S., Je, J. E., Yoon, J. H., Thorne, S. H., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.008 · Cited by 303
In Situ Gene Therapy for Adenocarcinoma of the Prostate: A Phase I Clinical Trial
Herman, J. R., Adler, H. L., Aguilar-Cordova, E., Rojas-Martinez, A., Woo, S., Timme, T. L., Wheeler, T. M., Thompson, T. C., & Scardino, P. T. (1999) · Human Gene Therapy · doi:10.1089/10430349950018229 · Cited by 301
(2000) · PubMed · Cited by 295
Oncolytic viral therapies – the clinical experience
Aghi, M., & Martuza, R. L. (2005) · Oncogene · doi:10.1038/sj.onc.1209037 · Cited by 288
A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.
Suzuki, K., Fueyo-Margareto, J., Krasnykh, V. N., Reynolds, P. N., Curiel, D. T., & Alemany, R. (2001) · PubMed · Cited by 286
Oncolytic herpes simplex virus vectors for cancer virotherapy
Varghese, S., & Rabkin, S. D. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700537 · Cited by 264
Genotoxicity of Retroviral Integration In Hematopoietic Cells
Nienhuis, A. W., Dunbar, C. E., & Sorrentino, B. P. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.001 · Cited by 258
Rescue and propagation of fully retargeted oncolytic measles viruses
Nakamura, T., Peng, K.-W., Harvey, M., Greiner, S., Lorimer, I. A. J., James, C. D., & Russell, S. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1060 · Cited by 252
Phuong, L. K., Allen, C., Peng, K. W., Giannini, C., Greiner, S. M., TenEyck, C. J., Mishra, P. K., Macura, S. I., Russell, S. J., & Galanis, E. (2003) · PubMed · Cited by 248
Uyttenhove, C., Maryanski, J., & Boon, T. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.3.1040 · Cited by 245
Foamy virus vector integration sites in normal human cells
Trobridge, G. D., Miller, D. G., Jacobs, M. A., Allen, J. M., Kiem, H.-P., Kaul, R., & Russell, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510046103 · Cited by 236
Wong, L. H., Krauer, K. G., Hatzinisiriou, I., Estcourt, M. J., Hersey, P., Tam, N. D., Edmondson, S., Devenish, R. J., & Ralph, S. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28779 · Cited by 234
Fernandez, M., Porosnicu, M., Markovic, D., & Barber, G. N. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.895-904.2002 · Cited by 222
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection
Morizono, K., Xie, Y., Ringpis, G.-E., Johnson, M., Nassanian, H., Lee, B., Wu, L., & Chen, I. S. Y. (2005) · Nature Medicine · doi:10.1038/nm1192 · Cited by 220
Newcastle disease virus (NDV): brief history of its oncolytic strains
Sinkovics, J. G., & Horvath, J. C. (2000) · Journal of Clinical Virology · doi:10.1016/s1386-6532(99)00072-4 · Cited by 219
Treatment of human cancer with mumps virus
Asada, T. (1974) · Cancer · doi:10.1002/1097-0142(197412)34:6<1907::aid-cncr2820340609>3.0.co;2-4 · Cited by 213
Kim, J.-H., Lee, Y.-S., Kim, H., Huang, J.-H., Yoon, A.-R., & Yun, C.-O. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj397 · Cited by 210
Metapopulation dynamics and spatial heterogeneity in cancer
González-García, I., Solé, R. V., & Costa, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202139299 · Cited by 201
MTH-68/H Oncolytic Viral Treatment in Human High-Grade Gliomas
Csatary, L. K., Gosztonyi, G., Szeberenyi, J., Fabian, Z., Liszka, V., Bodey, B., & Csatary, C. M. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000021735.85511.05 · Cited by 200
Dingwell, K. S., & Johnson, D. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8933-8942.1998 · Cited by 194
Epidemiology and outcomes of serious influenza‐related infections in the cancer population
Cooksley, C. D., Avritscher, E. B. C., Bekele, B. N., Rolston, K. V., Geraci, J. M., & Elting, L. S. (2005) · Cancer · doi:10.1002/cncr.21203 · Cited by 191
Recchia, A., Bonini, C., Magnani, Z., Urbinati, F., Sartori, D., Muraro, S., Tagliafico, E., Bondanza, A., Stanghellini, M. T. L., Bernardi, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507496103 · Cited by 189
Heinzerling, L., Künzi, V., Oberholzer, P. A., Kündig, T., Naim, H., & Dummer, R. (2005) · Blood · doi:10.1182/blood-2004-11-4558 · Cited by 188
Schuster, M., Nechansky, A., & Kircheis, R. (2006) · Biotechnology Journal · doi:10.1002/biot.200500044 · Cited by 179
In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
Rogulski, K. R., Freytag, S. O., Zhang, K., Gilbert, J. D., Paielli, D. L., Kim, J. H., Heise, C. C., & Kirn, D. H. (2000) · PubMed · Cited by 178
Systemic reovirus therapy of metastatic cancer in immune-competent mice.
Hirasawa, K., Nishikawa, S. G., Norman, K. L., Coffey, M. C., Thompson, B., Yoon, C., Waisman, D. M., & Lee, P. W. K. (2003) · PubMed · Cited by 173
Gene Therapy for Malignant Glioma: Current Clinical Status
Pulkkanen, K. J., & Yla-Herttuala, S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.357 · Cited by 161
Krishnamurthy, S., Takimoto, T., Scroggs, R. A., & Portner, A. (2006) · Journal of Virology · doi:10.1128/jvi.02618-05 · Cited by 158
Shafren, D. R., Au, G. G., Nguyen, T. P., Newcombe, N. G., Haley, E. S., Beagley, L., Johansson, E., Hersey, P., & Barry, R. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0690-3 · Cited by 158
Why we're losing the war on cancer (and how to win it).
Leaf, C. (2004) · PubMed · Cited by 156
Ren, H., Boulikas, T., Söling, A., Warnke, P. C., & Rainov, N. G. (2003) · Journal of Neuro-Oncology · doi:10.1007/bf02700029 · Cited by 155
Ikeda, K., Wakimoto, H., Ichikawa, T., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4765-4775.2000 · Cited by 154
Systemic tumor targeting and killing by Sindbis viral vectors
Tseng, J., Levin, B., Hurtado, A. M., Yee, H. T., de Castro, I. P., Jiménez, M., Shamamian, P. E., Jin, R., Novick, R. P., Pellicer, À., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt917 · Cited by 152
Vesicular Stomatitis Virus as an Oncolytic Vector
Barber, G. N. (2004) · Viral Immunology · doi:10.1089/vim.2004.17.516 · Cited by 138
Kim, M., Zinn, K. R., Barnett, B. G., Sumerel, L. A., Krasnykh, V. N., Curiel, D. T., & Douglas, J. T. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00131-4 · Cited by 136
Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
van Beusechem, V. W., van den Doel, P. B., Grill, J., Pinedo, H. M., & Gerritsen, W. R. (2002) · PubMed · Cited by 133
Rolls, M. M., Webster, P. C., Balba, N. H., & Rose, J. K. (1994) · Cell · doi:10.1016/0092-8674(94)90258-5 · Cited by 132
Colombo, F., Barzon, L., Franchin, E., Pacenti, M., Pinna, V., Danieli, D., Zanusso, M., & Palù, G. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700851 · Cited by 129
Guo, Z. S., Naik, A. M., O’Malley, M. E., Popovič, P., DeMarco, R., Hu, Y., Yin, X., Yang, S., Zeh, H. J., Moss, B., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1630 · Cited by 126
Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and Challenges
Mahdavi, A., & Monk, B. J. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-528 · Cited by 123
Ganly, I., Eckhardt, S. G., Rodriguez, G. I., et al. (2000) · Clinical Cancer Research · Cited by 123
Oncolytic adenoviruses – selective retargeting to tumor cells
Mathis, J. M., Stoff‐Khalili, M. A., & Curiel, D. T. (2005) · Oncogene · doi:10.1038/sj.onc.1209044 · Cited by 122
Targeting Human Glioblastoma Cells: Comparison of Nine Viruses with Oncolytic Potential
Wollmann, G., Tattersall, P. J., & van den Pol, A. N. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6005-6022.2005 · Cited by 122
Canine parvovirus-like particles, a novel nanomaterial for tumor targeting
Singh, P. N. P., Destito, G., Schneemann, A., & Manchester, M. (2006) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-4-2 · Cited by 120
Ebert, O., Shinozaki, K., Huang, T., Savontaus, M., García‐Sastre, A., & Woo, S. L. C. (2003) · PubMed · Cited by 120
Adeno-associated virus vectors: potential applications for cancer gene therapy
Li, C., Bowles, D. E., Dyke, T. V., & Samulski, R. J. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700876 · Cited by 117
Geoerger, B., Grill, J., Opolon, P., Morizet, J., Aubert, G., Terrier‐Lacombe, M., Paillerets, B. B., Barrois, M., Feunteun, J., Kirn, D. H., et al. (2002) · PubMed · Cited by 117
Novozhilov, A. S., Berezovskaya, F., Koonin, E. V., & Karev, G. P. (2006) · Biology Direct · doi:10.1186/1745-6150-1-6 · Cited by 117
Tai, C.-K., Wang, W. J., Chen, T. C., & Kasahara, N. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.017 · Cited by 116
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
Huneycutt, B. S., Bi, Z., Aoki, C. J., et al. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6698-6706.1993 · Cited by 115
O’Shea, C. C., Soria, C. T., Bagus, B., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.009 · Cited by 112
Ahlert, T., Sauerbrei, W., Bastert, G., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1354 · Cited by 106
In Vivo Targeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral Vectors
Palma, M. D., Venneri, M. A., & Naldini, L. (2003) · Human Gene Therapy · doi:10.1089/104303403322168028 · Cited by 106
Hemminki, A., Kanerva, A., Kremer, E. J., Bauerschmitz, G. J., Smith, B. F., Liu, B., Wang, M., Desmond, R. A., Keriel, A., Barnett, B. G., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00049-7 · Cited by 105
Rayet, B., López‐Guerrero, J. A., Rommelaere, J., & Dinsart, C. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8893-8903.1998 · Cited by 100
Rodríguez-Madoz, J. R., Prìeto, J., & Smerdou, C. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.02.011 · Cited by 96
Hobohm, U. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602386 · Cited by 94
The Complement Response Against an Oncolytic Virus Is Species-Specific in Its Activation Pathways
Wakimoto, H., Ikeda, K., Abé, T., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0547 · Cited by 93
Specific tumor-cell killing with adenovirus vectors containing the apoptin gene
Pietersen, A. M., van der Eb, M. M., Rademaker, H. J., van den Wollenberg, D. J. M., Rabelink, M. J. W. E., Kuppen, P. J. K., van Dierendonck, J. H., van Ormondt, H., Masman, D., van de Velde, C. J. �., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300876 · Cited by 91
Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses
Vecil, G. G., & Lang, F. F. (2003) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000003653.45635.32 · Cited by 90
Springfeld, C., von Messling, V., Frenzke, M. E., Ungerechts, G., Buchholz, C. J., & Cattaneo, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0538 · Cited by 90
Measles Infection of the Central Nervous System
Schneider‐Schaulies, J., ter Meulen, V., & Schneider‐Schaulies, S. (2003) · Journal of NeuroVirology · doi:10.1080/13550280390193993 · Cited by 89
Hilleman, M. R. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00529-2 · Cited by 88
Recombinant Baculovirus Containing the Diphtheria Toxin A Gene for Malignant Glioma Therapy
Wang, C., Li, F., Yang, Y. Y., Guo, H., Wu, C., & Wang, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4514 · Cited by 88
Levenson, V., Davidovich, I., & Roninson, I. B. (2000) · PubMed · Cited by 87
Ward, P. L., Koeppen, H., Hurteau, T., Rowley, D. A., & Schreiber, H. W. (1990) · PubMed · Cited by 87
Hassan, M., van der Meulen‐Muileman, I. H., Abbas, S., & Kruyt, F. A. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12243-12251.2004 · Cited by 85
Thomsen, A. R. (1997) · International Immunology · doi:10.1093/intimm/9.11.1757 · Cited by 85
Oncolytic Viral Therapy for Cervical and Ovarian Cancer Cells by Sindbis Virus AR339 Strain
Unno, Y., Shino, Y., Kondo, F., Igarashi, N., Wang, G., Shimura, R., Yamaguchi, T., Asano, T., Saisho, H., Sekiya, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2610 · Cited by 85
Dupressoir, T., Vanacker, J.-M., Cornelis, J. J., Duponchel, N., & Rommelaere, J. (1989) · PubMed · Cited by 84
Induced Apoptosis Supports Spread of Adenovirus Vectors in Tumors
Mi, J., Li, Z., Ni, S., Steinwaerder, D. S., & Lieber, A. (2001) · Human Gene Therapy · doi:10.1089/104303401750270995 · Cited by 83
Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21
Au, G. G., Lindberg, A., Barry, R. D., et al. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.6.1471 · Cited by 83
Replicative retroviral vectors for cancer gene therapy
Solly, S. K., Trajcevski, S., Frisén, C., Holzer, G. W., Nelson, E., Clerc, B., Abordo‐Adesida, E., Castro, M. G., Lowenstein, P. R., & Klatzmann, D. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700521 · Cited by 80
Hacker, U. T., Wingenfeld, L., Kofler, D. M., Schuhmann, N., Lutz, S., Herold, T., King, S. B. S., Gerner, F. M., Perabò, L., Rabinowitz, J. E., et al. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.782 · Cited by 76
Krone, B., Kölmel, K. F., Grange, J. M., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00625-7 · Cited by 75
Labrada, L., Bodelón, G., Viñuela, J. E., & Benavente, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.7932-7941.2002 · Cited by 75
Bilbao, R., Bustos, M., Alzuguren, P., Pajares, M. J., Droździk, M., Qian, C., & Prìeto, J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301312 · Cited by 74
Clinical evaluation of adenoviral-mediated p53 gene transfer: Review of INGN 201 studies
Merritt, J. A., Roth, J. A., & Logothetis, C. J. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90288-x · Cited by 74
The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer
Zhao, L., Dong, A., Gu, J., Liu, Z., Zhang, Y., Zhang, W., Wang, Y., He, L., Qian, C., Qian, Q., et al. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700969 · Cited by 73
Glasgow, J. N., Kremer, E. J., Hemminki, A., et al. (2004) · Virology · doi:10.1016/j.virol.2004.03.028 · Cited by 72
Vaccination against human cancers (review).
Sinkovics, J. G., & Horvath, J. C. (2000) · International Journal of Oncology · doi:10.3892/ijo.16.1.81 · Cited by 71
Common community respiratory viruses in patients with cancer
Hicks, K. L., Chemaly, R. F., & Kontoyiannis, D. P. (2003) · Cancer · doi:10.1002/cncr.11353 · Cited by 71
Tumor specific phage particles promote tumor regression in a mouse melanoma model
Eriksson, F., Culp, W. D., Massey, R., Egevad, L., Garland, D. L., Persson, M. A. A., & Pisa, P. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0227-6 · Cited by 69
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer
Myers, R. M., Greiner, S. M., Harvey, M. E., Soeffker, D., Frenzke, M. E., Abraham, K. G., SHAW, A. R., Rozenblatt, S., Federspiel, M. J., Russell, S. J., et al. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700823 · Cited by 68
Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Post, D. E., Fulci, G., Chiocca, E. A., et al. (2004) · Current Gene Therapy · doi:10.2174/1566523044577988 · Cited by 68
McKisic, M. D., Paturzo, F. X., & Smith, A. L. (1996) · Transplantation · doi:10.1097/00007890-199601270-00022 · Cited by 65
Ochiai, H., Campbell, S. A., Archer, G. E., Chewning, T. A., Dragunsky, E. M., Ap, I., Gromeier, M., & Sampson, J. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1595 · Cited by 65
Rapid Functional Exhaustion and Deletion of CTL following Immunization with Recombinant Adenovirus
Krebs, P., Scandella, E., Odermatt, B., & Ludewig, B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4559 · Cited by 64
Campoli, M. R., Ferrone, S., Zea, A. H., Rodríguez, P. C., & Ochoa, A. C. (2007) · Springer eBooks · doi:10.1007/0-387-27545-2_3 · Cited by 64
Su, C., Peng, L., Sham, J. S. T., Wang, X., Zhang, Q., Chua, D. T.-T., Liu, C., Cui, Z., Xue, H., Wu, H., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.12.011 · Cited by 64
HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy
Epstein, A. L., Marconi, P., Argnani, R., & Manservigi, R. (2005) · Current Gene Therapy · doi:10.2174/156652305774329285 · Cited by 64
Not all viruses are bad guys: the case for reovirus in cancer therapy
Norman, K. L., & Lee, P. W. K. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03483-5 · Cited by 63
Voeks, D. J., Martiniello‐Wilks, R., Madden, V., Smith, K., Bennetts, E., Both, G. W., & Russell, P. J. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301698 · Cited by 63
Bangari, D. S., Shukla, S., & Mittal, S. K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.099 · Cited by 63
Vlachaki, M. T., Hernández, A., Ittmann, M., Chhikara, M., Aguilar, L. K., Zhu, X., The, B. S., Butler, E. B., Woo, S. Y., Thompson, T. C., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0669 · Cited by 62
Development of the PANVAC™-VF vaccine for pancreatic cancer
Petrulio, C., & Kaufman, H. L. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.1.9 · Cited by 60
Tseng, J., Hurtado, A. M., Yee, H. T., Levin, B., Boivin, C., Benet, M., Blank, S. V., Pellicer, À., & Meruelo, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1924 · Cited by 59
Karev, G. P., Novozhilov, A. S., & Koonin, E. V. (2006) · Biology Direct · doi:10.1186/1745-6150-1-30 · Cited by 59
Sarkar, D., Su, Z.-Z., Vozhilla, N., Park, E. S., Randolph, A. L., Valerie, K. C., & Fisher, P. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1261 · Cited by 56
Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L
García, M. Á., Guerra, S., Gil, J., Jiménez, V., & Estéban, M. (2002) · Oncogene · doi:10.1038/sj.onc.1206036 · Cited by 54
Mundschau, L. J., & Faller, D. V. (1994) · Biochimie · doi:10.1016/0300-9084(94)90083-3 · Cited by 52
Djeha, A. H., Thomson, T. A., Leung, H. Y., Searle, P. F., Young, L. S., Kerr, D. J., Harris, P. A., Mountain, A., & Wrighton, C. J. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0250 · Cited by 52
Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin
Olijslagers, S., Dege, A. Y., Dinsart, C., et al. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700392 · Cited by 51
Wagner, S., Csatary, C. M., Gosztonyi, G., et al. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_516.x · Cited by 50
Mantwill, K., Köhler-Vargas, N., Bernshausen, A., Bieler, A., Lage, H., Kaszubiak, A., Surowiak, P., Dravits, T., Treiber, U., Härtung, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2339 · Cited by 49
Kinoh, H., Inoue, M., Washizawa, K., Yamamoto, T., Fujikawa, S., Tokusumi, Y., Iida, A., Nagai, Y., & Hasegawa, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302272 · Cited by 48
Mastrangelo, M. J., & Lattime, E. C. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700538 · Cited by 46
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody
Würdinger, T., Verheije, M. H., Raaben, M., Bosch, B., de Haan, C. A. M., van Beusechem, V. W., Rottier, P. J. M., & Gerritsen, W. R. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302535 · Cited by 42
Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery
Löser, P., Hüser, A., Hillgenberg, M., Kümin, D., Both, G. W., & Hofimann, C. (2002) · Current Gene Therapy · doi:10.2174/1566523024605555 · Cited by 42
Harding, T. C., Lalani, A. S., Roberts, B. N., Yendluri, S., Luan, B., Koprivnikar, K. E., Gonzalez-Edick, M., Huan-Tu, G., Musterer, R., VanRoey, M. J., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.02.004 · Cited by 42
Enhanced gene transfer activity of peptide-targeted gene-delivery vectors
Parker, A. L., Fisher, K. D., Oupický, D., Read, M. L., Nicklin, S. A., Baker, A. H., & Seymour, L. W. (2005) · Journal of drug targeting · doi:10.1080/10611860400020449 · Cited by 42
Arlen, P. M., Pazdur, M. P., Skarupa, L., Rauckhorst, M., & Gulley, J. L. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.032 · Cited by 40
Transduction of human glial and neuronal tumor cells with different lentivirus vector pseudotypes
Steffens, S., Tebbets, J. C., Kramm, C. M., Lindemann, D., Flake, A. W., & Sena‐Esteves, M. (2004) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-6046-8 · Cited by 39
Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr.
Pang, S., Kang, M., Kung, S., Yu, D., Lee, A., Poon, B., Chen, I. S., Lindemann, B., & Park, N. (2001) · PubMed · Cited by 38
Cancer Gene Therapy through Autonomous Parvovirus - Mediated Gene Transfer
Cornelis, J. J., Lang, S. I., Stroh-Dege, A., Balboni, G., Dinsart, C., & Rommelaere, J. (2004) · Current Gene Therapy · doi:10.2174/1566523043346228 · Cited by 36
Genetically modified adenoviruses against gliomas
Gomez‐Manzano, C., Yung, W. K. A., Alemany, R., & Fueyo-Margareto, J. (2004) · Neurology · doi:10.1212/01.wnl.0000133302.15022.7f · Cited by 36
Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas
Shinoura, N., Yoshida, Y., Asai, A., et al. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700160 · Cited by 36
Nakayama, M., Both, G. W., Banizs, B., et al. (2006) · Virology · doi:10.1016/j.virol.2006.01.037 · Cited by 35
Guan, M., Rodríguez-Madoz, J. R., Alzuguren, P., Gomar, C., Kramer, M. G., Kochanek, S., Prìeto, J., Smerdou, C., & Qian, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0877 · Cited by 34
van der Zeijst, B. A. M., Noyes, B. E., Mirault, M.-É., PARKER, B. S., Osterhaus, A. D. M. E., Swyryd, E. A., Bleumink‐Pluym, N. M. C., Horzinek, M. C., & Stark, G. R. (1983) · Journal of Virology · doi:10.1128/jvi.48.1.249-261.1983 · Cited by 32
Exhaustion of Type I Interferon Response following an Acute Viral Infection
Alsharifi, M., Regner, M., Blanden, R. V., Lobigs, M., Lee, E., Koskinen, A. M. L., & Müllbacher, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3235 · Cited by 32
Griffith, T. S., Kawakita, M., Tian, J. P., Ritchey, J., Tartaglia, J., Sehgal, I., Thompson, T. C., Zhao, W., & Ratliff, T. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.998 · Cited by 32
Dupont, F., Avalosse, B. L., Karim, A., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301161 · Cited by 31
Dragunsky, E. M., Taffs, R. E., Chernokhvostova, Y., Nomura, T., Hioki, K., Gardner, D. J., Norwood, L. P., & Levenbook, I. S. (1996) · Biologicals · doi:10.1006/biol.1996.0010 · Cited by 30
Gao, Q., Huang, X., Tang, D., Cao, Y., Chen, G., Lu, Y., Zhuang, L., Wang, S., Xu, G., Zhou, J., et al. (2006) · APOPTOSIS · doi:10.1007/s10495-006-9421-4 · Cited by 29
Oncolytic adenoviruses as antiglioma agents
Jiang, H., McCormick, F. P., Lang, F. F., Gomez‐Manzano, C., & Fueyo-Margareto, J. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.5.697 · Cited by 28
Hampl, J. A., Camp, S. M., Mydlarz, W. K., Hampl, M., Ichikawa, T., Chiocca, E. A., Louis, D. N., Sena‐Esteves, M., & Breakefield, X. O. (2003) · Human Gene Therapy · doi:10.1089/104303403321618137 · Cited by 27
Sinkovics, J., & Horvath, J. C. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.4.765 · Cited by 26
Hellebrand, E., Mautner, J., Reisbach, G., Nimmerjahn, F., Hallek, M. J., Mocikat, R., & Hammerschmidt, W. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302602 · Cited by 26
Growth properties of a human melanoma cell line are altered by adeno‐associated parvovirus type 2
Bantel‐Schaal, U. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600223 · Cited by 24
Iseki, H., Shimizukawa, R., Sugiyama, F., Kunita, S., Iwama, A., Onodera, M., Nakauchi, H., & Yagami, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8886-8893.2005 · Cited by 24
Shashkova, E. V., Черенова, Л. В., Kazansky, D. B., & Doronin, K. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700822 · Cited by 23
Redirecting Coronavirus to a Nonnative Receptor through a Virus-Encoded Targeting Adapter
Verheije, M. H., Würdinger, T., van Beusechem, V. W., de Haan, C. A. M., Gerritsen, W. R., & Rottier, P. J. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1250-1260.2006 · Cited by 21
Cordelier, P., Bienvenu, C., Lulka, H., Marrache, F., Bouisson, M., Openheim, A., Strayer, D. S., Vaysse, N., Pradayrol, L., & Buscail, L. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700987 · Cited by 20
Bovine enterovirus as an oncolytic virus: Foetal calf serum facilitates its infection of human cells
Smyth, M., Symonds, A. L. J., Brazinova, S., et al. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.10.1.49 · Cited by 19
Metzl, C., Mischek, D., Salmons, B., Günzburg, W. H., Renner, M., & Portsmouth, D. (2006) · Journal of Virology · doi:10.1128/jvi.00020-06 · Cited by 19
Massari, I., Donnini, A., Argentati, K., Straino, S., Mangoni, A., Gaetano, C., Viticchi, C., Capogrossi, M. C., & Provinciali, M. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00011-6 · Cited by 18
Mastrangelo, G., Rossi, C. R., Pfahlberg, A. B., Marzia, V., Barba, A., Baldo, M. J. M., Fadda, E., Milan, G., & Kölmel, K. F. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007658503740 · Cited by 16
Heinkelein, M., Hoffmann, U., Lücke, M., Imrich, H., Müller, J. G., Meixensberger, J., Westphahl, M., Kretschmer, A., & Rethwilm, A. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700855 · Cited by 16
Lou, E. (2004) · Annals of Medicine · doi:10.1080/07853890310016315 · Cited by 15
Wagner, R. R. (1954) · PubMed · Cited by 11
Destruction of Tumour Cells by Rift Valley Fever Virus
TAKEMORI, N., Nakano, M., Hemmi, M., Ikeda, H., YANAGIDA, S., & KITAOKA, M. (1954) · Nature · doi:10.1038/174698b0 · Cited by 8
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Oncolytic viruses: a new class of immunotherapy drugs
Kaufman, H. L., Kohlhapp, F. J., & Zloza, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4663 · Cited by 1,642
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
Classification of current anticancer immunotherapies
Galluzzi, L., Vacchelli, E., Pedro, J.-M. B.-S., Buqué, A., Senovilla, L., Baracco, E. E., Bloy, N., Castoldi, F., Abastado, J.-P., Agostinis, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2998 · Cited by 468
The Role of Phenolic Compounds in the Fight against Cancer – A Review
Carocho, M., & Ferreira, I. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990301 · Cited by 267
Metadata
- Authors
- Vähä-Koskela, M. J. V., Heikkilä, J. E., & Hinkkanen, A. E.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 254
- Issue
- 2
- Pages
- 178-216
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2081689148
- Cited by
- 333
- References
- 181
- FWCI
- 14.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.